A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Recent news on Moxifloxacin Hcl


Efficacy of Once-Daily Moxifloxacin in Treating Complicated Intra ...  Oct 13, 2006
SAN FRANCISCO, CA -- October 13, 2006 -- The efficacy of monotherapy with the once-daily, broad-spectrum antibiotic Avelox® (moxifloxacin HCl) in the ... -DG News Quest for New Antibiotics to Fight Drug Resistant Infections Gets ...  Sep 12, 2006
...of death in America's senior citizens 65 and older, but there appears to be new hope in this battle from a newer antibiotic, moxifloxacin HCl, marketed as ... -SeniorJournal.com

Avelox (Moxifloxacin) Excels in Comparison with Highly Potent ...  Sep 5, 2006
5, 2006--Avelox® (moxifloxacin HCl) 400mg sequential intravenous to oral monotherapy given once a day is as effective as the potent combination of high-dose ... -PharmaLive.com

Avelox(R) (Moxifloxacin) excels in comparison with highly potent ...  Sep 6, 2006
LEVERKUSEN, Germany | Sep 05, 2006 | Avelox® (moxifloxacin HCl) 400mg sequential intravenous to oral monotherapy given once a day is as effective as the ... -PipelineReview.com

Study shows Avelox monotherapy to be a highly effective, safe and ...  Sep 6, 2006
5 Sep 2006 , Leverkusen : Avelox® (moxifloxacin HCl) 400mg sequential intravenous to oral monotherapy given once a day is as effective as the potent ... -Prdomain Business Register

Avelox As Effective As Multi-dose Combination Therapy For Intra ...  Jul 28, 2006
Schering-Plough Corporation (NYSE: SGP) today reported that monotherapy with the once-daily, broad-spectrum antibiotic AVELOX (moxifloxacin HCl) was as ... -Medical News Today

Schering’s AVELOX® Shown Effective in Study and Merck Announces ...  Jul 26, 2006
Schering-Plough Corporation (NYSE: SGP) recently reported that monotherapy with the once-daily, broad-spectrum antibiotic AVELOX® (moxifloxacin HCl) was as ... -Financial News USA

Avelox As Effective As Multi-Dose Combination Therapy for Intra ...  Jul 26, 2006
Schering-Plough Corporation reported that monotherapy with the once-daily, broad-spectrum antibiotic AVELOX (moxifloxacin HCl) was as effective and well ... -eMaxHealth.com



Schering-Plough Reports Financial Results for First Quarter of ...  Apr 20, 2006
...(Announced March 20) * Reported results of a new clinical study showing that AVELOX (moxifloxacin HCl) monotherapy at 400 mg once daily was as effective as the ... - PR Newswire





Moxifloxacin Monotherapy as Effective as High-Dose Levofloxacin ...  Apr 7, 2006
KENILWORTH, NJ -- April 7, 2006 -- Avelox® (moxifloxacin HCl) monotherapy at 400 mg once daily is as effective as the high-dose combination of levofloxacin ... - DG News

AVELOX(R) Monotherapy as Effective as High-Dose Levofloxacin and ...  Apr 7, 2006
KENILWORTH, NJ, April 7 /PRNewswire-FirstCall/ -- AVELOX(R) (moxifloxacin HCl) monotherapy at 400 mg once daily is as effective as the high-dose combination of ... - PR Newswire

AVELOX(R) Monotherapy as Effective as High-Dose Levofloxacin and ...  Apr 7, 2006
...of Clinical Microbiology and Infectious Diseases (ECCMID) KENILWORTH, NJ, April 7 /PRNewswire-FirstCall/ -- AVELOX(R) (moxifloxacin HCl) monotherapy at 400 mg ... - PR Newswire

Vaccinated Senior Citizens Less Likely to Die from Pneumonia  Mar 16, 2006
...of death in America's senior citizens 65 and older, but there appears to be new hope in this battle from a newer antibiotic, moxifloxacin HCl, marketed as ... - SeniorJournal.com

Alcon and Allergan Reach Agreement on Brimonidine 0.15% Patent ...  Mar 9, 2006
Alcon believes this suit was intended to target Vigamox(R) (0.5% moxifloxacin HCl ophthalmic solution), Alcon's leading ophthalmic ocular antibiotic in the US. ... - Genetic Engineering News

Head-To-Head Study Shows More Elderly Patients With Community ...  Jan 24, 2006
24 /PRNewswire-FirstCall/ -- Significantly more elderly patients treated with AVELOX(R) (moxifloxacin HCl) for community-acquired pneumonia (CAP) recovered at ... - PR Newswire

Bayer Drug Better Than Leading Pneumonia Treatment  Jan 28, 2006
Significantly more elderly patients treated with the Bayer drug Avelox (moxifloxacin HCl) for community-acquired pneumonia (CAP) recovered at days three to ... - International News Service

Head-To-Head Study Shows More Elderly Patients With Community ...  Jan 24, 2006
KENILWORTH, NJ, January 24, 2006 /PRNewswire-FirstCall/ -- Significantly more elderly patients treated with AVELOX(R) (moxifloxacin HCl) for community-acquired ... - PharmaLive.com

Newer Antibiotic more Effective at Treating Pneumonia in Senior ...  Jan 24, 2006
...of death in America's senior citizens 65 and older, but there appears to be new hope in this battle from a newer antibiotic, moxifloxacin HCl, marketed as ... - SeniorJournal.com

Newer Antibiotic More Effective At Treating Elders' Pneumonia  Jan 24, 2006
Treated with the newer medication, moxifloxacin HCl, 97.9 percent of hospitalized patients recovered within three to five days of therapy onset, compared to 90 ... - DG News

(PRN) - Emerging Market for Omega-3 Fatty Acids Gains Ground ... ...  Jan 24, 2006
...(PRN) - Head-To-Head Study Shows More Elderly Patients With Community-Acquired Pneumonia Recovered at Days 3 to 5 With AVELOX(R) (Moxifloxacin HCl) Compared to ... - Bolsamania.com


This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional